Document Type : Research articles

Authors

1 Traditional Medicine and Materia Medica Research Center and Department of Traditional Pharmacy, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

4 Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Background: Herbal medicines are preferred over chemical medications for a wide range of mental disorders such as depression. "Monzej-e soda" is a polyherbal combination that has been used in Iranian traditional medicine for several years to cure different mood disorders with similar signs to depression. Traditional formulations should be reformulated to reach pharmacopoeial standards as modern medicines.
Objectives: In this study, "Monzej-e soda" was reformulated and its quality control and antidepressant evaluations were performed to present a standard and efficacious formulation.
Methods: The aqueous extract of the mixture of Echium amoenum, Lavandula angustifolia, Melissa officinalis, Foeniculum vulgare, Ziziphus jujuba, Cordia myxa, Glycyrrhiza glabra, Fumaria parviflora, Adiantum capillus-veneris, and Alhagi spp. manna was dried with the spray drying method. Dried extract and various ingredients at different ratios were used to produce 13 experimental tablet formulations and several pre- and post-formulation tests were performed to select the best formulation. The formulation was evaluated physico-chemically. The accelerated stability test was performed on the tablets, as well. Moreover, the antidepressant effect of tablets was evaluated by the forced swimming test. The serum levels of serotonin (5-HT), noradrenaline (NA), and brain-derived neurotropic factor (BDNF) were measured in rats. Finally, histopathological examinations were performed on the liver, kidney, and spleen.
Results: Among different formulations, the best one was a combination of dried extract (490 mg), maltodextrin (189 mg), colloidal silicon dioxide (21 mg), and croscarmellose sodium (2%). The hardness, weight, friability, disintegration time, dissolution percentage, and total phenolic content were 6.98 kg/cm2, 715.76 mg, 0.7%, 12.0 min, 97.46% in one hour, and 31.4 mg/tab, respectively. No significant changes were seen in the product in the accelerated stability test. The polyherbal tablet produced significant antidepressant effects through the decrease in immobility time, which was mediated via an increase in NA and 5-HT levels. It had no effect on the BDNF level. In addition, tablets had no toxic effects on the liver, kidney, and spleen.
Conclusions: "Monzej-e soda" tablet can be considered a suitable antidepressant drug and used in patients after passing clinical trial tests.

Keywords

  1. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370(9590):851-8. doi: 10.1016/S0140-6736(07)61415-9. [PubMed: 17826170].
  2. Carrellas NW, Biederman J, Uchida M. How prevalent and morbid are subthreshold manifestations of major depression in adolescents? A literature review. J Affect Disord. 2017;210:166-73. doi: 10.1016/j.jad.2016.12.037. [PubMed: 28049101].
  3. Liang Y, Yang X, Zhang X, Duan H, Jin M, Sun Y, et al. Antidepressant-like effect of the saponins part of ethanol extract from SHF. J Ethnopharmacol. 2016;191:307-14. doi: 10.1016/j.jep.2016.06.044. [PubMed: 27321411].
  4. Ye L, Hu Z, Du G, Zhang J, Dong Q, Fu F, et al. Antidepressant-like effects of the extract from Cimicifuga foetida L. J Ethnopharmacol. 2012;144(3):683-91. doi: 10.1016/j.jep.2012.10.013. [PubMed: 23069943].
  5. Zakerin S, Rezghi M, Hajimehdipoor H, Ara L, Hamzeloo-Moghadam M. Antidepressant effect of a polyherbal syrup based on Iranian traditional medicine. Res J Pharmacogn. 2019;6(2):49-56. doi: 10.22127/rjp.2019.84318.
  6. Sanchez-Vidana DI, Ngai SP, He W, Chow JK, Lau BW, Tsang HW. The effectiveness of aromatherapy for depressive symptoms: A systematic review. Evid Based Complement Alternat Med. 2017;2017:5869315. doi: 10.1155/2017/5869315. [PubMed: 28133489]. [PubMed Central: PMC5241490].
  7. Hormati A, Tooiserkany F, Mohammadbeigi A, Aliasl F, Moradi Dehnavi H. Effect of an herbal product on the serum level of liver enzymes in patients with non-alcoholic fatty liver disease: A randomized, double-blinded, placebo-controlled trial. Iran Red Crescent Med J. 2019;21(7). doi: 10.5812/ircmj.91024.
  8. Richelson E. Pharmacology of antidepressants--characteristics of the ideal drug. Mayo Clin Proc. 1994;69(11):1069-81. doi: 10.1016/s0025-6196(12)61375-5. [PubMed: 7967761].
  9. Majumder P, Paridhavi M. Physiocochemical standardization and formulation development of poly-herbal tablet for diabetes. British J Pharm Res. 2016;12(3):1-17. doi: 10.9734/bjpr/2016/26599.
  10. Shah Arzani M. Mizan-O-Teb. Qom: Sama Cultural Institute; 2001. p. 25-8.
  11. Zargaran A, Daneshamouz S, Kordafshari G, Mohagheghzadeh A. Report - Renovation of a traditional Ergh-al-Nassa pill (Hab) to a standard Pharmaceutical molded tablet. Pak J Pharm Sci. 2016;29(5):1703-9. [PubMed: 27731832].
  12. Davoodi A, Jouybari HB, Fathi H, Ebrahimnejad P. Formulation and physicochemical evaluation of medlar (mespilus germanica l.) and oak (quercus castaneifolia c.A. Mey.) effervescent tablets. Int J Pharm Sci Res. 2018;9(9):3870-5. doi: 10.13040/ijpsr.0975-8232.9(9).3870-75.
  13. Enriquez-Castillo A, Alamilla J, Barral J, Gourbiere S, Flores-Serrano AG, Gongora-Alfaro JL, et al. Differential effects of caffeine on the antidepressant-like effect of amitriptyline in female rat subpopulations with low and high immobility in the forced swimming test. Physiol Behav. 2008;94(3):501-9. doi: 10.1016/j.physbeh.2008.03.004. [PubMed: 18436269].
  14. The British Pharmacopoeia Commission. Britsh Pharmacopoeia. London: The Stationary Office; 2011.
  15. Allen L, Ansel HC. Ansel's pharmaceutical dosage forms and drug delivery systems. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 184-92.
  16. The United States Pharmacopoeial Convention. The United States Pharmacopoeia XXXVIII and National Formulary XXXIII. Rockville (MD): The United States Pharmacopoeial Convention; 2014. 342 p.
  17. Fitzpatrick S, McCabe JF, Petts CR, Booth SW. Effect of moisture on polyvinylpyrrolidone in accelerated stability testing. Int J Pharm. 2002;246(1-2):143-51. doi: 10.1016/s0378-5173(02)00375-7. [PubMed: 12270617].
  18. Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioural despair in rats: A new model sensitive to antidepressant treatments. Eur J Pharmacol. 1978;47(4):379-91. doi: 10.1016/0014-2999(78)90118-8. [PubMed: 204499].
  19. Rowe RC, Sheskey PJ, Owen SC. Handbook of pharmaceutical excipients. London: Pharmaceutical press; 2006.
  20. Santos Júnior AF, Barbosa IS, Santos VL, Silva RL, Caetite Junior E. Test of dissolution and comparison of in vitro dissolution profiles of coated ranitidine tablets marketed in Bahia, Brazil. Brazil J Pharm Sci. 2014;50(1):83-9. doi: 10.1590/s1984-82502011000100008.
  21. Wang W, Hu X, Zhao Z, Liu P, Hu Y, Zhou J, et al. Antidepressant-like effects of liquiritin and isoliquiritin from Glycyrrhiza uralensis in the forced swimming test and tail suspension test in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(5):1179-84. doi: 10.1016/j.pnpbp.2007.12.021. [PubMed: 18289754].
  22. Elhwuegi AS. Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(3):435-51. doi: 10.1016/j.pnpbp.2003.11.018. [PubMed: 15093950].
  23. Nutt DJ. The neuropharmacology of serotonin and noradrenaline in depression. Int Clin Psychopharmacol. 2002;17 Suppl 1:S1-12. doi: 10.1097/00004850-200206001-00002. [PubMed: 12369606].
  24. Sayyah M, Boostani H, Pakseresht S, Malaieri A. Efficacy of aqueous extract of Echium amoenum in treatment of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(8):1513-6. doi: 10.1016/j.pnpbp.2009.08.021. [PubMed: 19737592].
  25. Sayyah M, Sayyah M, Kamalinejad M. A preliminary randomized double blind clinical trial on the efficacy of aqueous extract of Echium amoenum in the treatment of mild to moderate major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(1):166-9. doi: 10.1016/j.pnpbp.2005.10.005. [PubMed: 16309809].
  26. Rabiei Z, Rabiei S. A review on antidepressant effect of medicinal plants. Bangladesh J Pharmacol. 2017;12(1):1. doi: 10.3329/bjp.v12i1.29184.
  27. Akhondzadeh S, Kashani L, Fotouhi A, Jarvandi S, Mobaseri M, Moin M, et al. Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: A double-blind, randomized trial. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(1):123-7. doi: 10.1016/s0278-5846(02)00342-1. [PubMed: 12551734].
  28. Nikfarjam M, Rakhshan R, Ghaderi H. Comparison of effect of Lavandula officinalis and venlafaxine in treating depression: A double blind clinical trial. J Clin Diagn Res. 2017;11(7):KC01-4. doi: 10.7860/JCDR/2017/20657.10233. [PubMed: 28892932]. [PubMed Central: PMC5583809].
  29. Taiwo AE, Leite FB, Lucena GM, Barros M, Silveira D, Silva MV, et al. Anxiolytic and antidepressant-like effects of Melissa officinalis (lemon balm) extract in rats: Influence of administration and gender. Indian J Pharmacol. 2012;44(2):189-92. doi: 10.4103/0253-7613.93846. [PubMed: 22529473]. [PubMed Central: PMC3326910].
  30. Alijaniha F, Naseri M, Afsharypuor S, Fallahi F, Noorbala A, Mosaddegh M, et al. Heart palpitation relief with Melissa officinalis leaf extract: Double blind, randomized, placebo controlled trial of efficacy and safety. J Ethnopharmacol. 2015;164:378-84. doi: 10.1016/j.jep.2015.02.007. [PubMed: 25680840].
  31. Dhingra D, Sharma A. Antidepressant-like activity of Glycyrrhiza glabra L. in mouse models of immobility tests. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(3):449-54. doi: 10.1016/j.pnpbp.2005.11.019. [PubMed: 16443316].
  32. Ofir R, Tamir S, Khatib S, Vaya J. Inhibition of serotonin re-uptake by licorice constituents. J Mol Neurosci. 2003;20(2):135-40. doi: 10.1385/JMN:20:2:135. [PubMed: 12794307].
  33. Yusup A, Halip A, Imam G, Upur H. The effect of Abnormal Savda Munziq (ASMq) on serum levels of neuroendocrine in depression animal models [J]. J Xinjiang Med Univ. 2011;12.
  34. Halip A, Imam G, Yusup A, Upur H. The effect of Abnormal Savda Munziq (ASMq) on biological syndromes of depression animal models [J]. J Xinjiang Med Univ. 2011;12.